应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LENZ Therapeutics
盘前交易 07-30 07:49:23 EDT
31.67
+0.16
+0.51%
最高
32.49
最低
31.02
成交量
35.80万
今开
31.87
昨收
31.51
日振幅
4.67%
总市值
8.91亿
流通市值
4.03亿
总股本
2,815万
成交额
1,144万
换手率
2.81%
流通股本
1,273万
市净率
4.64
ROE
-24.47%
每股收益
-1.77
52周最高
38.93
52周最低
16.54
市盈率
-17.90
股息
0.00
股息收益率
0.00
ROA
-17.75%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Windtree Therapeutics, Inc.7月29日成交额为528.52万美元
市场透视 · 08:38
Windtree Therapeutics, Inc.7月29日成交额为528.52万美元
Transcode Therapeutics, Inc.7月29日成交额为100.35万美元
市场透视 · 05:51
Transcode Therapeutics, Inc.7月29日成交额为100.35万美元
Entero Therapeutics Inc.7月29日成交额为5.71万美元
市场透视 · 02:09
Entero Therapeutics Inc.7月29日成交额为5.71万美元
Crispr Therapeutics Ag7月29日成交额为2.52亿美元
市场透视 · 01:47
Crispr Therapeutics Ag7月29日成交额为2.52亿美元
Galectin Therapeutics Inc.盘中异动 股价大涨5.21%
市场透视 · 07-29 18:16
Galectin Therapeutics Inc.盘中异动 股价大涨5.21%
Jasper Therapeutics, Inc.盘中异动 下午盘快速下挫5.48%报2.93美元
市场透视 · 07-29 17:39
Jasper Therapeutics, Inc.盘中异动 下午盘快速下挫5.48%报2.93美元
Intellia Therapeutics, Inc.盘中异动 快速下跌5.00%
市场透视 · 07-29 15:20
Intellia Therapeutics, Inc.盘中异动 快速下跌5.00%
4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.53%
市场透视 · 07-29 15:09
4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.53%
Monte Rosa Therapeutics, Inc.盘中异动 大幅下挫5.23%
市场透视 · 07-29 14:25
Monte Rosa Therapeutics, Inc.盘中异动 大幅下挫5.23%
Alaunos Therapeutics, Inc.盘中异动 股价大跌5.00%
市场透视 · 07-29 14:20
Alaunos Therapeutics, Inc.盘中异动 股价大跌5.00%
Kyverna Therapeutics, Inc.盘中异动 股价大跌5.97%
市场透视 · 07-29 14:13
Kyverna Therapeutics, Inc.盘中异动 股价大跌5.97%
Black Diamond Therapeutics, Inc.盘中异动 早盘大幅跳水5.12%
市场透视 · 07-29 13:55
Black Diamond Therapeutics, Inc.盘中异动 早盘大幅跳水5.12%
Tenaya Therapeutics, Inc.盘中异动 股价大跌5.04%
市场透视 · 07-29 13:39
Tenaya Therapeutics, Inc.盘中异动 股价大跌5.04%
Prelude Therapeutics Incorporated盘中异动 股价大涨17.31%
市场透视 · 07-29 13:38
Prelude Therapeutics Incorporated盘中异动 股价大涨17.31%
Autolus Therapeutics Plc盘中异动 大幅跳水5.14%报2.38美元
市场透视 · 07-29 13:35
Autolus Therapeutics Plc盘中异动 大幅跳水5.14%报2.38美元
PTC Therapeutics盘前涨超10%
格隆汇 · 07-29 09:45
PTC Therapeutics盘前涨超10%
Windtree Therapeutics, Inc.7月28日成交额为430.94万美元
市场透视 · 07-29 08:32
Windtree Therapeutics, Inc.7月28日成交额为430.94万美元
Cognition Therapeutics, Inc.7月28日成交额为498.79万美元
市场透视 · 07-29 01:34
Cognition Therapeutics, Inc.7月28日成交额为498.79万美元
Sarepta Therapeutics股票即将恢复交易
DoNews · 07-28 21:40
Sarepta Therapeutics股票即将恢复交易
Werewolf Therapeutics, Inc.盘中异动 早盘股价大涨5.15%报1.43美元
市场透视 · 07-28 15:20
Werewolf Therapeutics, Inc.盘中异动 早盘股价大涨5.15%报1.43美元
加载更多
公司概况
公司名称:
Therapeutics
所属市场:
NASDAQ
上市日期:
2021-06-25
主营业务:
LENZ Therapeutics, Inc.于2017年6月1日加拿大安大略省注册成立,并于2019年10月在特拉华州重新注册。他们是一家临床阶段的下一代基因编辑公司,利用高效靶向基因整合开发新型疗法有可能治愈范围广泛的严重和危及生命的疾病。他们正在开创一种精确的基因编辑方法,以实现医学上最难以实现的目标之一:精确“找到并替换”基因组中的任何基因。他们的下一代基因编辑平台使他们能够精确地纠正突变,用正常基因替换整个致病基因,或将新基因插入预定的安全位置。
发行价格:
17.00
{"stockData":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":31.67,"timestamp":1753819200000,"preClose":31.51,"halted":0,"volume":357999,"delay":0,"floatShares":12729900,"shares":28146154,"eps":-1.769251,"marketStatus":"盘前交易","change":0.16,"latestTime":"07-30 07:49:20 EDT","open":31.87,"high":32.49,"low":31.02,"amount":11438210.175603,"amplitude":0.046652,"askPrice":34.8,"askSize":100,"bidPrice":31.6,"bidSize":270,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753882200000},"marketStatusCode":1,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":31.67,"postHourTrading":{"tag":"盘后","latestPrice":31.67,"preClose":31.67,"latestTime":"17:56 EDT","volume":3695,"amount":117026.47,"timestamp":1753826195337},"volumeRatio":1.6748630656299257,"impliedVol":1.1476,"impliedVolPercentile":0.9342},"requestUrl":"/m/hq/s/LENZ","defaultTab":"news","newsList":[{"id":"2555017844","title":"Windtree Therapeutics, Inc.7月29日成交额为528.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555017844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555017844?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:38","pubTimestamp":1753864700,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日,Windtree Therapeutics, Inc.成交额为528.52万美元,成交额较昨日增加22.65%,当日成交量为655.02万股。Windtree Therapeutics, Inc.于2025年7月29日跌11.44%,报0.815美元,该股过去5个交易日跌18.49%,年初至今跌95.33%,过去60日跌18.49%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-29|528.52万|22.65%|655.02万|#|2025-07-28|430.94万|17.01%|452.57万|#|2025-07-25|368.30万|-76.74%|379.45万|#|2025-07-24|1583.25万|349.81%|1482.36万|#|2025-07-23|351.98万|-55.79%|358.81万|Windtree Therapeutics Inc 是一家生物技术公司,专注于推进针对危重疾病和疾病的早期和晚期疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730172609a46b50e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730172609a46b50e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","WINT","BK4539","WINTW","BK4139","BK4007"],"gpt_icon":0},{"id":"2555097631","title":"Transcode Therapeutics, Inc.7月29日成交额为100.35万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555097631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555097631?lang=zh_cn&edition=full","pubTime":"2025-07-30 13:51","pubTimestamp":1753854707,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日,Transcode Therapeutics, Inc.成交额为100.35万美元,成交额较昨日减少62.83%,当日成交量为8.01万股。Transcode Therapeutics, Inc.于2025年7月29日跌15.33%,报11.76美元,该股过去5个交易日涨24.58%,年初至今跌87.54%,过去60日跌25.53%。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730135149a6c90fa5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730135149a6c90fa5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RNAZ","LENZ","BK4007"],"gpt_icon":0},{"id":"2555909666","title":"Entero Therapeutics Inc.7月29日成交额为5.71万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555909666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555909666?lang=zh_cn&edition=full","pubTime":"2025-07-30 10:09","pubTimestamp":1753841385,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日,Entero Therapeutics Inc.成交额为5.71万美元,成交额较昨日增加14.31%,当日成交量为11.86万股。Entero Therapeutics Inc.于2025年7月29日跌0.04%,报0.471美元,该股过去5个交易日跌4.83%,年初至今跌24.26%,过去60日涨32.7%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-29|5.71万|14.31%|11.86万|#|2025-07-28|5.00万|109.40%|10.22万|#|2025-07-25|2.39万|-62.82%|5.03万|#|2025-07-24|6.42万|285.03%|13.32万|#|2025-07-23|1.67万|-57.70%|3.35万|Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司,专注于开发针对胃肠道疾病的靶向非全身性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730100947a6c8bea6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730100947a6c8bea6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ENTO","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2555095851","title":"Crispr Therapeutics Ag7月29日成交额为2.52亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555095851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555095851?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:47","pubTimestamp":1753840070,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日,Crispr Therapeutics Ag成交额为2.52亿美元,成交额较昨日增加132.35%,当日成交量为420.63万股。Crispr Therapeutics Ag于2025年7月29日跌7.42%,报59.02美元,该股过去5个交易日跌10.48%,年初至今涨49.95%,过去60日涨56.43%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写,是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy,它是与Vertex制药公司合作开发的,主要针对镰状细胞病和输血依赖型β-地中海贫血,这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730094756a46a8ae5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730094756a46a8ae5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4556","BK4139","LU1861559042.SGD","CRSP","BK4588","BK4007","LU1861558580.USD","LENZ","BK4611","BK4585"],"gpt_icon":0},{"id":"2555065980","title":"Galectin Therapeutics Inc.盘中异动 股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555065980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555065980?lang=zh_cn&edition=full","pubTime":"2025-07-30 02:16","pubTimestamp":1753812985,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日02时16分,Galectin Therapeutics Inc.股票出现异动,股价快速拉升5.21%。Galectin Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.67%。其相关个股中,Salarius Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Calidi Biotherapeutics, Inc.涨幅较大,Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃,换手率分别为5529.56%、3966.44%、1779.74%,振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.,振幅分别为176.76%、111.54%、75.60%。Galectin Therapeutics Inc.公司简介:Galectin Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730021625a46a129d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730021625a46a129d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GALT","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2555798063","title":"Jasper Therapeutics, Inc.盘中异动 下午盘快速下挫5.48%报2.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555798063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555798063?lang=zh_cn&edition=full","pubTime":"2025-07-30 01:39","pubTimestamp":1753810781,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日01时39分,Jasper Therapeutics, Inc.股票出现波动,股价快速跳水5.48%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.60%。其相关个股中,Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃,换手率分别为5506.19%、3705.59%、1746.90%,振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.,振幅分别为176.76%、111.54%、75.60%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730013941a46a0c9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730013941a46a0c9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","JSPR","LENZ","BK4007"],"gpt_icon":0},{"id":"2555050567","title":"Intellia Therapeutics, Inc.盘中异动 快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555050567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555050567?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:20","pubTimestamp":1753802436,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时20分,Intellia Therapeutics, Inc.股票出现波动,股价大幅下挫5.00%。Intellia Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。Intellia Therapeutics, Inc.公司简介:Intellia Therapeutics 是一家基因编辑公司,致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系,以推进其产品线的发展,其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292320379725ae9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292320379725ae9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","LENZ","BK4556","NTLA","LU1861559042.SGD","BK4585","LU1861558580.USD","BK4539","BK4588","BK4139","BK4007"],"gpt_icon":0},{"id":"2555605040","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555605040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555605040?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:09","pubTimestamp":1753801772,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时09分,4D Molecular Therapeutics, Inc.股票出现波动,股价快速下跌5.53%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.38%。其相关个股中,Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Sarepta Therapeutics, Inc.涨幅较大,Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃,换手率分别为5180.95%、3100.88%、1593.01%,振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.,振幅分别为112.00%、111.54%、75.60%。4D Molecular Therapeutics, Inc.公司简介:4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司,从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292309329725aab4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292309329725aab4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","FDMT","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2555057590","title":"Monte Rosa Therapeutics, Inc.盘中异动 大幅下挫5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555057590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555057590?lang=zh_cn&edition=full","pubTime":"2025-07-29 22:25","pubTimestamp":1753799142,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日22时25分,Monte Rosa Therapeutics, Inc.股票出现异动,股价快速下跌5.23%。Monte Rosa Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.27%。Monte Rosa Therapeutics, Inc.公司简介:Monte Rosa Therapeutics Inc是一家生物技术公司,专门开发分子胶降解剂,这是一类利用人体天然蛋白质破坏机制选择性降解治疗相关蛋白质的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072922254397259a64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072922254397259a64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GLUE","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2555052749","title":"Alaunos Therapeutics, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555052749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555052749?lang=zh_cn&edition=full","pubTime":"2025-07-29 22:20","pubTimestamp":1753798830,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日22时20分,Alaunos Therapeutics, Inc.股票出现异动,股价急速下跌5.00%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。其相关个股中,Scinai Immunotherapeutics Ltd、Calidi Biotherapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Scinai Immunotherapeutics Ltd、Tnf Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为4657.22%、1435.73%、416.15%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.、Adial Pharmaceuticals, Inc,振幅分别为106.73%、75.60%、46.98%。Alaunos Therapeutics, Inc.公司简介:Alaunos Therapeutics Inc是一家临床阶段的细胞免疫肿瘤学公司,致力于通过采用TCR-T细胞疗法治疗实体肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729222030a469d91d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729222030a469d91d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","TCRT","BK4007"],"gpt_icon":0},{"id":"2555522200","title":"Kyverna Therapeutics, Inc.盘中异动 股价大跌5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555522200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555522200?lang=zh_cn&edition=full","pubTime":"2025-07-29 22:13","pubTimestamp":1753798428,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日22时13分,Kyverna Therapeutics, Inc.股票出现异动,股价急速下挫5.97%。截至发稿,该股报4.07美元/股,成交量5.0998万股,换手率0.12%,振幅7.82%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.36%。其相关个股中,Salarius Pharmaceuticals, Inc.、Scinai Immunotherapeutics Ltd、Calidi Biotherapeutics, Inc.涨幅较大,Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃,换手率分别为4115.08%、2496.21%、1402.23%,振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.,振幅分别为111.98%、106.73%、75.60%。Kyverna Therapeutics, Inc.公司简介:Kyverna Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729221348a6c80331&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729221348a6c80331&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYTX","LENZ","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2555205228","title":"Black Diamond Therapeutics, Inc.盘中异动 早盘大幅跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555205228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555205228?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:55","pubTimestamp":1753797340,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时55分,Black Diamond Therapeutics, Inc.股票出现异动,股价快速跳水5.12%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。其相关个股中,180 Life Sciences Corp C/Wts 07/11/2025、Surrozen Inc C/Wts 01/08/2031 、Calidi Biotherapeutics, Inc.涨幅较大,Scinai Immunotherapeutics Ltd、Tnf Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为3514.19%、1334.01%、371.50%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Adial Pharmaceuticals, Inc、Scinai Immunotherapeutics Ltd,振幅分别为106.73%、46.98%、43.41%。Black Diamond Therapeutics, Inc.公司简介:Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司,开发针对癌症患者致癌突变家族的 MasterKey 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921554197258f08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921554197258f08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","BDTX","BK4007"],"gpt_icon":0},{"id":"2555526470","title":"Tenaya Therapeutics, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555526470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555526470?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:39","pubTimestamp":1753796346,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时39分,Tenaya Therapeutics, Inc.股票出现异动,股价大幅跳水5.04%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.06%。Tenaya Therapeutics, Inc.公司简介:Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司,专注于发现、开发和提供治疗性疗法,解决心脏病的潜在驱动因素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921390694c1a829&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921390694c1a829&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","TNYA","BK4007"],"gpt_icon":0},{"id":"2555461054","title":"Prelude Therapeutics Incorporated盘中异动 股价大涨17.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555461054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555461054?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:38","pubTimestamp":1753796281,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时38分,Prelude Therapeutics Incorporated股票出现波动,股价快速上涨17.31%。Prelude Therapeutics Incorporated股票所在的生物技术行业中,整体涨幅为0.13%。Prelude Therapeutics Incorporated公司简介:Prelude Therapeutics Incorp是一家临床阶段的精准肿瘤学公司,专注于发现和开发针对癌症关键驱动机制的小分子疗法,以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729213801a469ca1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729213801a469ca1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PRLD","BK4539","BK4505","BK4139","BK4007"],"gpt_icon":0},{"id":"2555549470","title":"Autolus Therapeutics Plc盘中异动 大幅跳水5.14%报2.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555549470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555549470?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:35","pubTimestamp":1753796150,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时35分,Autolus Therapeutics Plc股票出现波动,股价急速跳水5.14%。截至发稿,该股报2.38美元/股,成交量29.7486万股,换手率0.11%,振幅5.38%。Autolus Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.07%。Autolus Therapeutics Plc公司简介:Autolus Therapeutics PLC 是一家生物制药公司,致力于开发用于治疗癌症的下一代程序化 T 细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921355097258793&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921355097258793&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AUTL","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2555503283","title":"PTC Therapeutics盘前涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555503283","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555503283?lang=zh_cn&edition=full","pubTime":"2025-07-29 17:45","pubTimestamp":1753782349,"startTime":"0","endTime":"0","summary":"格隆汇7月29日|生物制药公司PTC Therapeutics的代谢疾病治疗药物获FDA批准,股价盘前涨超10%。巴克莱银行上调其目标价至46美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072917482497252381&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072917482497252381&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4023","LU2362541513.USD","BK4539","LU0320765992.SGD","BK4554","BK4007","LU1951200564.SGD","LU2506952410.USD","BK4585","LU2506952337.HKD","PTC","LU0109394709.USD","LU2362541273.HKD","BK4576","LU2362540622.SGD","LU0889565916.HKD","LU1721428347.USD","LU1923623000.USD","BK4588","BK4139","LENZ","PTCT","LU2477742899.HKD","LU1951198990.SGD"],"gpt_icon":0},{"id":"2555034810","title":"Windtree Therapeutics, Inc.7月28日成交额为430.94万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555034810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555034810?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:32","pubTimestamp":1753777962,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日,Windtree Therapeutics, Inc.成交额为430.94万美元,成交额较昨日增加17.01%,当日成交量为452.57万股。Windtree Therapeutics, Inc.于2025年7月28日跌6.08%,报0.92美元,该股过去5个交易日跌7.03%,年初至今跌94.73%,过去60日跌21.33%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-28|430.94万|17.01%|452.57万|#|2025-07-25|368.30万|-76.74%|379.45万|#|2025-07-24|1583.25万|349.81%|1482.36万|#|2025-07-23|351.98万|-55.79%|358.81万|#|2025-07-22|796.07万|-39.12%|809.48万|Windtree Therapeutics Inc 是一家生物技术公司,专注于推进针对危重疾病和疾病的早期和晚期疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729172359a6c792b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729172359a6c792b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","WINT","BK4539","WINTW","BK4139","BK4007"],"gpt_icon":0},{"id":"2555408805","title":"Cognition Therapeutics, Inc.7月28日成交额为498.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555408805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555408805?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:34","pubTimestamp":1753752848,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日,Cognition Therapeutics, Inc.成交额为498.79万美元,成交额较昨日增加84.25%,当日成交量为687.58万股。Cognition Therapeutics, Inc.于2025年7月28日跌14.87%,报0.715美元,该股过去5个交易日涨2.16%,年初至今涨2.01%,过去60日涨67.47%。该公司的候选产品CT1812是一种口服小分子拮抗剂,旨在穿透血脑屏障并选择性地与S2R复合物结合。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729093649a6c6ca9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729093649a6c6ca9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","CGTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2555704145","title":"Sarepta Therapeutics股票即将恢复交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2555704145","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555704145?lang=zh_cn&edition=full","pubTime":"2025-07-29 05:40","pubTimestamp":1753738802,"startTime":"0","endTime":"0","summary":"北京时间2025年7月30日凌晨05:40,基因疗法公司Sarepta Therapeutics Inc.(SRPT)股票将在纽约证券交易所恢复交易。此次恢复交易时间为纽约时间17:40,标志着该公司此前因特殊事项暂停的股票交易重新启动。市场人士正密切关注其股价变动情况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072905412094c00a70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072905412094c00a70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","BK4539","IE00B2B36J28.USD","SRPT","BK4007","BK4139","LENZ","IE0002141913.USD","BK4585","IE00BJT1NW94.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2554858708","title":"Werewolf Therapeutics, Inc.盘中异动 早盘股价大涨5.15%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554858708","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554858708?lang=zh_cn&edition=full","pubTime":"2025-07-28 23:20","pubTimestamp":1753716025,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日23时20分,Werewolf Therapeutics, Inc.股票出现异动,股价大幅上涨5.15%。Werewolf Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.09%。其相关个股中,Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Abpro Holdings, Inc涨幅较大,Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃,换手率分别为432.11%、210.03%、121.90%,振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ,振幅分别为125.48%、82.93%、75.48%。Werewolf Therapeutics, Inc.公司简介:Werewolf Therapeutics Inc 是一家生物制药公司,致力于开创性地开发用于治疗癌症的、旨在刺激人体免疫系统的治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072823202594bf9696&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072823202594bf9696&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","HOWL","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.graphitebio.com","stockEarnings":[{"period":"1week","weight":-0.0397},{"period":"1month","weight":0.0494},{"period":"3month","weight":0.1106},{"period":"6month","weight":0.2429},{"period":"1year","weight":0.3147},{"period":"ytd","weight":0.097}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.0331},{"period":"3month","weight":0.1456},{"period":"6month","weight":0.0499},{"period":"1year","weight":0.1661},{"period":"ytd","weight":0.0839}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"LENZ Therapeutics, Inc.于2017年6月1日加拿大安大略省注册成立,并于2019年10月在特拉华州重新注册。他们是一家临床阶段的下一代基因编辑公司,利用高效靶向基因整合开发新型疗法有可能治愈范围广泛的严重和危及生命的疾病。他们正在开创一种精确的基因编辑方法,以实现医学上最难以实现的目标之一:精确“找到并替换”基因组中的任何基因。他们的下一代基因编辑平台使他们能够精确地纠正突变,用正常基因替换整个致病基因,或将新基因插入预定的安全位置。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.169631},{"month":2,"riseRate":0.5,"avgChangeRate":0.077415},{"month":3,"riseRate":0.25,"avgChangeRate":-0.098838},{"month":4,"riseRate":0.5,"avgChangeRate":-0.02248},{"month":5,"riseRate":0.25,"avgChangeRate":-0.134416},{"month":6,"riseRate":0.75,"avgChangeRate":0.05507},{"month":7,"riseRate":0.6,"avgChangeRate":0.066045},{"month":8,"riseRate":0.25,"avgChangeRate":-0.053734},{"month":9,"riseRate":0.5,"avgChangeRate":-0.017856},{"month":10,"riseRate":0.75,"avgChangeRate":0.006056},{"month":11,"riseRate":0.5,"avgChangeRate":-0.013543},{"month":12,"riseRate":0.5,"avgChangeRate":0.070925}],"exchange":"NASDAQ","name":"Therapeutics","nameEN":"Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Therapeutics(LENZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Therapeutics,LENZ,Therapeutics股票,Therapeutics股票老虎,Therapeutics股票老虎国际,Therapeutics行情,Therapeutics股票行情,Therapeutics股价,Therapeutics股市,Therapeutics股票价格,Therapeutics股票交易,Therapeutics股票购买,Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Therapeutics(LENZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}